AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.45%143.900.7%$893.02m
PFEPfizer Inc. -1.12%37.070.9%$763.99m
MRKMerck & Co., Inc. -0.24%78.080.7%$625.64m
BMYBristol-Myers Squibb Co. -1.09%59.981.0%$621.97m
ABBVAbbVie, Inc. -1.64%82.871.9%$591.65m
LLYEli Lilly & Co. -1.61%141.281.1%$483.68m
AZNAstraZeneca Plc -1.19%51.571.2%$202.18m
NVSNovartis AG -1.81%84.140.2%$142.02m
GSKGlaxoSmithKline Plc -1.92%35.350.2%$138.90m
NVONovo Nordisk A/S -0.56%70.850.1%$69.94m
RPRXRoyalty Pharma Plc -2.72%39.000.2%$63.66m
RGENRepligen Corp. -0.42%171.767.1%$62.43m
SNYSanofi -1.42%49.170.2%$49.98m
AMAGAMAG Pharmaceuticals, Inc. -0.07%13.6322.1%$45.03m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.77%77.760.0%$40.66m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.